Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome - PubMed (original) (raw)
Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
T J Gregory et al. J Clin Invest. 1991 Dec.
Abstract
Acute Respiratory Distress Syndrome (ARDS) is characterized by lung injury and damage to the alveolar type II cells. This study sought to determine if endogenous surfactant is altered in ARDS. Bronchoalveolar lavage was performed in patients at-risk to develop ARDS (AR, n = 20), with ARDS (A, n = 66) and in normal subjects (N, n = 29). The crude surfactant pellet was analyzed for total phospholipids (PL), individual phospholipids, SP-A, SP-B, and minimum surface tension (STmin). PL was decreased in both AR and A (3.48 +/- 0.61 and 2.47 +/- 0.40 mumol/ml, respectively) compared to N (7.99 +/- 0.60 mumol/ml). Phosphatidylcholine was decreased in A (62.64 +/- 2.20% PL) compared to N (76.27 +/- 2.05% PL). Phosphatidylglycerol was 11.58 +/- 1.21% PL in N and was decreased to 6.48 +/- 1.43% PL in A. SP-A was 123.64 +/- 20.66 micrograms/ml in N and was decreased to 49.28 +/- 21.68 micrograms/ml in AR and to 29.88 +/- 8.49 micrograms/ml in A. SP-B was 1.28 +/- 0.33 micrograms/ml in N and was decreased to 0.57 +/- 0.24 micrograms/ml in A. STmin was increased in AR (15.1 +/- 2.53 dyn/cm) and A (29.04 +/- 2.05 dyn/cm) compared to N (7.44 +/- 1.61 dyn/cm). These data demonstrate that the chemical composition and functional activity of surfactant is altered in ARDS. Several of these alterations also occur in AR, suggesting that these abnormalities occur early in the disease process.
Similar articles
- Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Günther A, et al. Am J Respir Crit Care Med. 1996 Jan;153(1):176-84. doi: 10.1164/ajrccm.153.1.8542113. Am J Respir Crit Care Med. 1996. PMID: 8542113 - Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R, Markart P, Ruppert C, Temmesfeld B, Nass R, Lohmeyer J, Seeger W, Günther A. Schmidt R, et al. Crit Care Med. 2006 Sep;34(9):2370-6. doi: 10.1097/01.CCM.0000234036.19145.52. Crit Care Med. 2006. PMID: 16849999 Clinical Trial. - Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
Todd DA, Marsh MJ, George A, Henderson NG, Barr H, Sebastian S, Clark GT, Koster G, Clark HW, Postle AD. Todd DA, et al. Pediatr Crit Care Med. 2010 Jan;11(1):82-91. doi: 10.1097/PCC.0b013e3181ae5a4c. Pediatr Crit Care Med. 2010. PMID: 19550365 - Composition and function of pulmonary surfactant in adult respiratory distress syndrome.
Hallman M, Maasilta P, Sipilä I, Tahvanainen J. Hallman M, et al. Eur Respir J Suppl. 1989 Mar;3:104s-108s. Eur Respir J Suppl. 1989. PMID: 2662993 Review. - Surfactant and the adult respiratory distress syndrome.
Lewis JF, Jobe AH. Lewis JF, et al. Am Rev Respir Dis. 1993 Jan;147(1):218-33. doi: 10.1164/ajrccm/147.1.218. Am Rev Respir Dis. 1993. PMID: 8420422 Review.
Cited by
- Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.
Murthy A, Rodriguez LR, Dimopoulos T, Bui S, Iyer S, Chavez K, Tomer Y, Abraham V, Cooper C, Renner DM, Katzen JB, Bentley ID, Ghadiali SN, Englert JA, Weiss SR, Beers MF. Murthy A, et al. Am J Physiol Lung Cell Mol Physiol. 2024 Aug 1;327(2):L232-L249. doi: 10.1152/ajplung.00324.2023. Epub 2024 Jun 11. Am J Physiol Lung Cell Mol Physiol. 2024. PMID: 38860845 - Life-saving effect of pulmonary surfactant in premature babies.
Raj JU, Bland RD, Bhattacharya J, Rabinovitch M, Matthay MA. Raj JU, et al. J Clin Invest. 2024 May 1;134(9):e179948. doi: 10.1172/JCI179948. J Clin Invest. 2024. PMID: 38690742 Free PMC article. - Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup.
Xu H, Sheng S, Luo W, Xu X, Zhang Z. Xu H, et al. Front Immunol. 2023 Nov 14;14:1277161. doi: 10.3389/fimmu.2023.1277161. eCollection 2023. Front Immunol. 2023. PMID: 38035100 Free PMC article. Review. - Hypertonic treatment of acute respiratory distress syndrome.
Li W, Martini J, Intaglietta M, Tartakovsky DM. Li W, et al. Front Bioeng Biotechnol. 2023 Oct 23;11:1250312. doi: 10.3389/fbioe.2023.1250312. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37936822 Free PMC article. - Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions.
Dushianthan A, Grocott MPW, Murugan GS, Wilkinson TMA, Postle AD. Dushianthan A, et al. Diagnostics (Basel). 2023 Sep 15;13(18):2964. doi: 10.3390/diagnostics13182964. Diagnostics (Basel). 2023. PMID: 37761330 Free PMC article. Review.
References
- J Clin Invest. 1965 Mar;44:458-64 - PubMed
- Eur J Biochem. 1967 Mar;1(1):80-91 - PubMed
- Clin Chest Med. 1990 Dec;11(4):593-619 - PubMed
- J Appl Physiol (1985). 1988 Aug;65(2):982-7 - PubMed
- Obstet Gynecol. 1987 Jul;70(1):94-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials